Package 0078-0357-52

Brand: trileptal

Generic: oxcarbazepine
NDC Package

Package Facts

Identity

Package NDC 0078-0357-52
Digits Only 0078035752
Product NDC 0078-0357
Product ID 0078-0357_dcd739ce-e938-40e6-8912-ca4f34b49cf3
Description

250 mL in 1 BOTTLE (0078-0357-52)

Marketing

Marketing Status
Marketed Since 2001-05-30
Brand trileptal
Generic oxcarbazepine
Sample Package No

Linked Drug Pages (1)

Trileptal ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "dcd739ce-e938-40e6-8912-ca4f34b49cf3", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["261356", "261360", "262090", "283536", "312136", "312137", "312138", "351992"], "spl_set_id": ["4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "250 mL in 1 BOTTLE (0078-0357-52)", "package_ndc": "0078-0357-52", "marketing_start_date": "20010530"}], "brand_name": "Trileptal", "product_id": "0078-0357_dcd739ce-e938-40e6-8912-ca4f34b49cf3", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0078-0357", "generic_name": "oxcarbazepine", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trileptal", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "60 mg/mL"}], "application_number": "NDA021285", "marketing_category": "NDA", "marketing_start_date": "20010530", "listing_expiration_date": "20261231"}